XML 34 R16.htm IDEA: XBRL DOCUMENT
v3.25.1

Noncontrolling Interests | 12 Months Ended
--- | ---
Mar. 31, 2025
Noncontrolling Interest [Abstract] |
Noncontrolling Interests | Noncontrolling Interests Noncontrolling Interests Noncontrolling interests represent third-party equity interests in the Company’s consolidated entities primarily related to ClarusONE, Vantage, and SCRI Oncology. After June 15, 2021, noncontrolling interests also represented minority shareholder equity interests in McKesson Europe. The Company’s noncontrolling interest in McKesson Europe was included in the divestiture of the E.U. disposal group in October 2022, as discussed in Financial Note 2, “Business Acquisitions and Divestitures.” Noncontrolling interests in the Company’s Consolidated Balance Sheets were $380 million and $372 million at March 31, 2025 and 2024, respectively. For the years ended March 31, 2025, 2024, and 2023, the Company allocated a total of $186 million, $158 million, and $162 million of net income to noncontrolling interests, respectively. Changes in noncontrolling interests for the years ended March 31, 2025, 2024, and 2023 were as follows:
(In millions) |  | Noncontrolling Interests
Balance, March 31, 2022 |  | $ | 480 |
Net income attributable to noncontrolling interests |  | 162 |
Other comprehensive income |  | 44 |
Payments to noncontrolling interests |  | (150) |
Reclassification of recurring compensation to other accrued liabilities |  | (5) |
Formation of SCRI Oncology |  | 225 |
Derecognition of noncontrolling interests in McKesson Europe |  | (382) |
Other |  | (7) |
Balance, March 31, 2023 |  | 367 |
Net income attributable to noncontrolling interests |  | 158 |
Payments to noncontrolling interests |  | (152) |
Other |  | (1) |
Balance, March 31, 2024 |  | 372 |
Net income attributable to noncontrolling interests |  | 186 |
Payments to noncontrolling interests |  | (178) |
Balance, March 31, 2025 |  | $ | 380 |

X
- Definition The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent + Details
Name: | us-gaap_MinorityInterestDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration